LAGUNA HILLS, Calif., March 19, 2026--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment ...
Please provide your email address to receive an email when new articles are posted on . Meta-analysis further supports catheter ablation vs. drug therapy for management of ventricular arrythmias in ...
vCLAS TM Used to Treat Patients with No Satisfactory Approved Treatment and/or Failed RF or PFA LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results